United States: Sessions Changes The US DOJ's Position On Prosecutorial Discretion Involving Marijuana In States Permitting Use – But Is That A Big Deal For Employers?

As predicted by Politico, the Wall Street Journal, Washington Post and other sources, U.S. Attorney General Jeff Sessions today rescinded the 2013 Cole Memorandum "Guidance Regarding Marijuana Enforcement," which has established US DOJ Prosecutorial Discretion toward medical and recreational marijuana users and producers in states with State laws. The Cole Memorandum was in turn a revision of the June 2011 and October 2009 Memorandums.

To oversimplify, the Cole Memorandum memorandum basically took a don't ask, don't tell - kind of approach, and stated that the US Department of Justice would not spend its resources to enforce Federal drug laws arguably in conflict with state laws on medical and recreational marijuana – at least where the regulatory structure was robust enough to limit distribution and production in violation of the US DOJ's overall priorities for Drug enforcement.

The new memorandum, which Politico has posted, rescind the Cole Memorandum and returns the US DOJ to return to "well-established" prosecutorial principles.

  • So the Sessions Memorandum does not set out specific goals or affirmatively state that the US DOJ is going to war on users and producers in compliance with state laws. The Memorandum simply rejects the nuanced guidance in place in different forms since 2009.

Today, the Wall Street Journal ably explained the result:

Attorney General Jeff Sessions Thursday is expected to rescind an Obama-era Justice Department policy that took a largely hands-off approach to the marijuana industry in states that have legalized the drug's sale for medical and recreational purposes, according to an official familiar with the plan.

The attorney general will instead permit local U.S. attorneys, the top federal prosecutors in the states, to decide whether to more aggressively enforce drug laws governing marijuana trafficking and sales.

The Sessions Memorandum will create more questions rather than answer them, but may or may not affect the current trends in employer and employee rights.

Relevance to Employers.

Marijuana remains a Schedule I Drug under the Controlled Substances Act (CSA) and is therefore unlawful under Federal Law ... period.

For a number of years, courts in states with medical or recreational marijuana laws have upheld an employer's right to require employees to report to work free from the presence of unlawfully used drugs and to take adverse action against them even when the state either legalized marijuana in some form and/or maintains a law protecting prohibiting employers from taking adverse action against employees for lawful off-duty conduct.

As an example, see the seminal Colorado decision, Coats v. Dish Network in which The Court rejected the argument that the General Assembly intended the term "lawful" to mean "lawful under Colorado state law:"

"We therefore agree with the Court of Appeals" ... "that the commonly accepted meaning of the term 'lawful' is 'that which is 'permitted by law' or, conversely, that which is 'not contrary to, or forbidden by law.'"

Generally, courts concluded that even if the state legalized some form of marijuana use, that use was still unlawful under the Controlled Substance Act (CSA). Thus the state laws did not change the definition of lawful for purposes of employment decisions. Likewise, the ADA and most disability discrimination laws would not protect marijuana use because that use was still unlawful under Federal Law.

Many states' marijuana laws also expressly or tacitly recognized the employer's right to maintain a drug free workplace and to take adverse action. Please follow this Link to my California Partners Danielle Moore and Benjamin Ebbink's recent piece on the California Marijuana law.

Safety Concerns.

Many employers are not troubled by employee off duty usage of marijuana, and may have sympathy with medical users; however, the active metabolites of marijuana stay in an employee's system after use and has been proven to affect higher levels of judgment and reflexes even days later. For this reason, regardless of an employer's personal opinions, most employers have continued to require employees to report to work free from the presence of unlawfully use drugs. As an example, review the National Highway Traffic Safety Administration Report to Congress and related studies.

The safety challenge is further complicated by the fact that there is no widely accepted method to determine a presumption of impairment based upon the use of marijuana; unlike alcohol. Various states are now experimenting with tests and presumptive standards, but it is unclear as to whether they are accurate or legally defensible in the longer run.

Moreover, even if one limits the requirement of being present in one's system to "safety-sensitive jobs," does this mean that impairment is acceptable for employees using their cars to perform work or to make crucial financial decisions or to enforce no-harassment protections? These are valid questions.

Changing Tide Toward Employees?

In 2017, we began to see some court decisions concluding that employers could not take adverse action against employees lawfully using marijuana under their state laws, in part because legislatures wrote some of the newer marijuana legislation to expressly protect employees.

As an example, in August, 2017 the Massachusetts Supreme Judicial Court held in Barbuto v. Advantage sales and Marketing that, as with the use of any properly prescribed medication, the use of lawfully prescribed marijuana must be accommodated - Chief Justice Gants stated that:

"an exception to an employer's drug policy to permit its use is a facially reasonable accommodation."

The Court left open the possibility that accommodating an employee's use of medical marijuana could pose an undue burden to employers, holding that the use of marijuana could impair performance or cause a safety issue, which would impose an undue burden on employers.

Such an analysis is essentially the analysis employers have used for years to evaluate licit employee drug use. The Court did confirm that the statute does not require employers to permit the use of medical marijuana in the workplace. See Boston FP Attorneys' Jeff Dretler and Josh Nadreau's take on Barbuto.

Or see In Callaghan v. Darlington Fabrics (R.I. Super. Ct., May 23, 2017), in which the Rhode Island Superior Court held that an employer could not refuse to hire a medical marijuana cardholder, even if the employee would not pass the employer's mandatory pre-employment drug test.

Will US Attorneys Really shift resources to such cases?

These decisions occurred while Marijuana was already a Schedule I Drug – and the CSA Schedule, not the Guidance memorandum, is the key to pro-employer decisions. There is also the issue of the Roharabacher-Blumenauer Amendment and whether it will be included in future spending bills and limit US DOJ efforts.Perhaps a US DOJ effort to actively prosecute marijuana producers and users will influence Courts considering the right of employers to take adverse action against users, but it is hard to see how the US DOJ's new stance will change those state Court's analysis.

Possible Action Points.

  1. On a State-by-State basis, learn about the Medical and Recreational marijuana laws and related issues in states in which you operate. Many such laws are analyzed on our FP Website, such as Lisa McGlynn an Ilanit Fischler's piece on the 2017 Florida Law.
  2. Track the Legislatures in states in which you operate, as does Fisher Phillips, and respond to new State Marijuana Laws which may be intended to get around court decisions finding that Federal Schedule I status made the use unlawful for purposes of employment decisions.
  3. Determine states where the state law has been interpreted or may be interpreted to require accommodation of medical marijuana users – don't make knee jerk decisions rather than going through an individualized interactive process.
  4. Analyze your states' medical and Recreational marijuana Laws. Many medical marijuana laws include restrictions on the conditions warranting marijuana use or the form of marijuana or its active elements.
  5. Determine your employee-philosophy with regard to medical marijuana usage. Weigh the risk of creating precedent of a reasonable accommodation versus employee morale and culture.
  6. Review your Job Descriptions for safety implications, as well as any essential functions that may be affected by residual marijuana presence.
  7. In states where use is lawful, think about how you will handle employees who are cited for driving while impaired while off duty, depending upon their duties.
  8. Rethink your drug testing decisions – as Marijuana use increases, are you losing good workers?
  • Focus more on the deadly opiates epidemic, which is far more harmful to employers than marijuana usage.

Fisher Phillips will be further discussing the implications of the DOJ change.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration
Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:
  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.
  • Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.
    If you do not want us to provide your name and email address you may opt out by clicking here
    If you do not wish to receive any future announcements of products and services offered by Mondaq you may opt out by clicking here

    Terms & Conditions and Privacy Statement

    Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

    Use of www.mondaq.com

    You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

    Disclaimer

    Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

    The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

    Registration

    Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

    • To allow you to personalize the Mondaq websites you are visiting.
    • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
    • To produce demographic feedback for our information providers who provide information free for your use.

    Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

    Information Collection and Use

    We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

    We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

    Mondaq News Alerts

    In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

    Cookies

    A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

    Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

    Log Files

    We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

    Links

    This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

    Surveys & Contests

    From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

    Mail-A-Friend

    If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

    Emails

    From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

    *** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .

    Security

    This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

    Correcting/Updating Personal Information

    If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

    Notification of Changes

    If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

    How to contact Mondaq

    You can contact us with comments or queries at enquiries@mondaq.com.

    If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.

    By clicking Register you state you have read and agree to our Terms and Conditions